Drug Database
Back to search

Netherlands· NL-2cc76ec7c9b3

Tuzulby 40 mg kauwtabletten met verlengde afgifte

A methylphenidate product containing methylfenidaathydrochloride, registered in Netherlands by Neuraxpharm Pharmaceuticals, S.L. The same ATC class is registered in 18 of our 19 countries.

ATC N06BA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTuzulby 40 mg kauwtabletten met verle…ATCN06BA04REGISTER NO.NL-2cc76ec7c9b3PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methylfenidaathydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Methylphenidate is registered in 18 of 19 countries.

Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search methylphenidate products by name

Methylphenidate · ATC N06BA04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylphenidate costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Methylphenidate · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.87
  • IT Italy$0.68
  • US United States$0.56 (acquisition cost)
  • FR France$0.56
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
METHYLFENIDAATHYDROCHLORIDE
Manufacturer
Neuraxpharm Pharmaceuticals, S.L
Country
Netherlands (NL)
ATC code
N06BA04
ATC class
Methylphenidate
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1907

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

196 interactions on record for methylphenidate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check methylphenidate against other medicinesHow interaction checks work

Methylphenidate · interactions on record

196 records

  • 12 severe
  • 45 moderate
  • 3 minor
  • 128 info

Most severe, free to view

  • ProcarbazineL01XB01severe
  • OzanimodL04AA38severe
  • OzanimodL04AE02severe
  • CocaineN01BC01severe

8 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylphenidate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylphenidate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Concerta, Conmethyl
  • Belgium · Atexam 18 Mg, Atexam 27 Mg
  • Bulgaria · Концерта
  • Cyprus · Concerta
  • Czechia · Balipre, Concerta
  • Germany · 5 Mg, Medikinet, 50 Mg, Medikinet Adult
  • Denmark · Concerta, Equasym Depot
  • Estonia · Affenid, Concerta
  • Spain · Atenza, Concerta
  • Finland · Atexam, Concerta
  • France · Concerta Lp, Lp
  • United Kingdom (Northern Ireland) · Addepta Xl, Affenid Xl
  • Greece · Concerta
  • Croatia · Concerta, Mefeda
  • Hungary · Ritalin, Ritalin La
  • Ireland · Concerta Xl, Equasym Xl
  • Iceland · Concerta, Equasym Depot
  • Italy · Equasym, Medikinet
  • Liechtenstein · Concerta, Tuzulby
  • Lithuania · Concerta, Medikinet
  • Luxembourg · Concerta, Equasym Xr
  • Latvia · Medikinet, Medikinet Xl
  • Malta · Concerta, Concerta Xl
  • Norway · Concerta, Delmosart
  • Poland · Adehader, Atenza
  • Portugal · Atexam, Concerta
  • Romania · Clorhidrat De Metilfenidat G.L. Pharma, Concerta
  • Sweden · Affenid, Concerta
  • Slovenia · Concerta
  • Slovakia · Balipre, Concerta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/be45b007-ab87-465c-a586-69799a280366
GET /v1/drugs/be45b007-ab87-465c-a586-69799a280366?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kauwtablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tuzulby-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Methylphenidate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp130832",
  "excipients": [
    "ASPARTAAM (E 951)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CITROENZUUR 0-WATER (E 330)",
    "CROSPOVIDON (E 1202)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "GUAR GOM (E 412)",
    "KERSENSMAAKSTOF",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "POLYSTYREENSULFONAAT NATRIUM",
    "POLYVINYLACETAAT",
    "POLYVINYLALCOHOL (E 1203)",
    "POVIDON (E 1201)",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE, GEHYDRATEERD (E 551)",
    "TALK (E 553b)",
    "XANTHAANGOM (E 415)"
  ],
  "substances": [
    "METHYLFENIDAATHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/02/28",
  "procedure_number": "EMEA/H/C/005975",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1907",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about methylphenidate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console